retatrutide clinical trials south africa Public health threat as battles illegal weight loss drugs Retatrutide Phase 3: TRIUMPH Program

The FDA's BeSafeRx website provides verification tools to locate authorized pharmacy providers

Editors Note: Following a May 2026 global consensus, polycystic ovary syndrome (PCOS) is now officially called polyendocrine metabolic ovarian syndrome (PMOS), highlighting the metabolic roots of the condition

In this trial involving adults with obesity, retatrutide demonstrated substantial weight reduction up to approximately 24% of body weight over 48 weeks a magnitude not previously observed with any approved pharmacological agent

Pancreatitis occurs rarely (0.1-0.2%) with both medications

But when it comes to an attractive space for dealmaking, private label and contract manufacturing arent to be overlooked